Max India announces the Embedded Value (EV) for Max Life at Rs. 5,363 Cr.

– Operating EV grows at annualised rate of 15%
– Structural new business margin at 20%
26th November 2015, New Delhi

Max India Ltd. today announced the Embedded Value (EV) for its life insurance business, Max Life, at Rs. 5,363 Cr. as at 30th September 2015, based on Market Consistent methodology. The annualised growth in Operating EV for H1 FY2016 is an impressive 14.8% before accounting for capital movements. The Return on EV (RoEV) is 13.8% over the previously declared EV of Rs. 5,232 Cr. as at 31st March 2015. The Value of New Business (VNB) written during H1 FY2016 is Rs 163 Cr with the new business margin at a strong 20.2%, before the cost overrun, and 17.0%, after the cost overrun. The growth is supported by strong fundamentals both on the existing business as well as a continued focus on new profitable business.

EV and VNB are important metrics for the valuation of a life insurance business as the company is generally valued at a multiple to its EV. For instance, Mitsui Sumitomo Insurance’s investment in Max Life Insurance was at an implied EV multiple of around 3 times.

The EV of a life insurance company comprises two key elements — a) Net Asset Value or the Net Worth of the company, which represents the market value of the company’s assets attributable to the shareholders, and b) the Present Value of the company’s future expected profits from its existing business portfolio as at the date of valuation.

Max Life had transitioned its EV calculation to a Market Consistent methodology from the earlier traditional approach (Traditional Embedded Value – TEV) in FY2015. This follows market practice in developed markets, where life insurers have moved to adopt market consistent methodologies.

A market consistent methodology approach better reflects the embedded value of an insurance company by explicitly allowing for insurance and economic risks rather than using an implicit overall allowance for risks through a Risk Discount Rate (RDR) in the traditional approach. In addition, the market-consistent approach is more objective where asset and liability cash flows are valued using assumptions consistent with those applied to similar cash flows in the capital markets.

About Max Group

Max Group is a leading Indian multi-business conglomerate with a commanding presence in the Life Insurance, Healthcare and Health Insurance sectors. In the financial year 2015, the Group recorded a consolidated turnover of Rs 14,877 Cr. It has a total customer base of over 7.5 million, nearly 300 offices spread across India and people strength of around 17,000 as on 31st March 2015. Max India Limited is a widely held company, listed on the BSE and the NSE. Its founder sponsor Analjit Singh holds 40.5% stake in the company. Other shareholders include some of the world’s best Institutional Investors such as Goldman Sachs, Temasek, IFC (Washington), Fidelity and New York Life.

About Max Life

Max Life Insurance Company Ltd. (MLIC) is a joint venture between Max India Ltd. and Mitsui Sumitomo Insurance Co. Ltd. Mitsui Sumitomo Insurance is a part of MS&AD Insurance Group, which is amongst the leading general insurers in the world. Max Life Insurance, one of India’s leading life insurers, offers comprehensive life insurance and retirement solutions for long-term savings and protection.

A financially strong and stable company with focus on quality of advice, sound investment expertise and service excellence, Max Life Insurance has set in place value-driven culture and corporate governance through its superior human capital. The Company has a countrywide diversified distribution model, including the country’s leading agent advisors, exclusive corporate agency arrangement with Axis Bank and several other partners.

– Max India Board to announce effective date for demerger of company into 3 separate listed entities in January 2016
– Max Financial Services expected to trade ex-demerger in January 2016, and the other resulting companies in February 2016
24th Dec 2015, New Delhi

The Hon’ble High Court of Punjab and Haryana vide its order dated 14th December 2015 approved Max India’s Composite Scheme of Arrangement for the demerger of the company. The shareholders of Max India have already given their consent on July 4, 2015, with over 99.9% voting in favor of the demerger, which will unlock value and provide undiluted access to the company’s businesses. In addition, the Insurance Regulatory and Development Authority of India (IRDAI), the Securities and Exchange Board of India (SEBI) and the Competition Commission of India (CCI) have already approved the demerger of Max India, into three separate listed entities. The court is expected to issue the detailed certified order shortly.

Upon receipt of the detailed certified order, the Company will file the same with the Registrar of Companies (RoC) for achieving ‘Effective Date’ of the demerger – the day the 3 legal entities will stand demerged.

On the Effective Date, the existing company, Max India will be renamed as Max Financial Services Limited. In addition, as per the sanctioned scheme, Resulting Company 1 i.e., Taurus Ventures Limited will be renamed as Max India Limited and Resulting Company 2, i.e., Capricorn Ventures Limited will be renamed as Max Ventures and Industries Limited. The demerged Max Financial Services Limited’s stock will start trading on the BSE as well as the NSE in a week from the Effective Date and the two additional companies are anticipated to list in about 45 days from the Effective Date.

Explaining the rationale for the restructuring, Mr. Rahul Khosla, Managing Director, Max India said, “The strategic restructuring and the underlying strength and potential of each business make them well positioned to deliver stellar performance going forward. One of the main benefits of the restructuring is to provide choice for investors to participate specifically in the growth of different sectors/industries. The restructuring and separate listings will also lead to a more accurate value discovery of each vertical. The market has responded extremely favourably in the past few months since we announced the restructuring in January and we hope the investors’ trust in us will only continue to grow from here.”

Commenting on the next steps in the restructuring exercise, Deputy Managing Director Mr. Mohit Talwar said, “The Court order has been a critical penultimate step towards the conclusion of the much awaited restructuring. We and our investors are now looking forward to the demerger and the resultant listing of the 3 demerged entities. We are seeing a significant amount of investor interest and shareholder confidence in all the listing entities.”

Post demerger, the three holding companies will be as follows:

a) Max Financial Services Limited will focus solely on, and manage the Group’s flagship life insurance activity, through its subsidiary Max Life Insurance, in which it holds 72% share, making it the first Indian listed company exclusively focused on life insurance.

b) The second listed company, Max India Limited will manage investments in the high potential Healthcare and Allied businesses. It will have three subsidiaries – Max Healthcare, Max Bupa and Antara Senior Living. The demerger will provide these businesses, which are currently in their growth and development phase, sharpened focus to fulfill their tremendous growth and value potential.

c) The third listed company, Max Ventures and Industries Limited (MVIL), will manage investment in the Group’s manufacturing subsidiary, Max Speciality Films – an innovation leader in the Speciality Packaging Films business. In addition, MVIL will explore fresh ideas for new ventures in the ‘wider world of business’.

Post restructuring, Max India’s existing shareholders will retain one equity share of Rs 2/- in Max Financial Services Limited. They will additionally get one equity share of Rs. 2/- each of the new company Max India Limited for every one equity share held in Max Financial Services and one equity share of Rs. 10/- each of Max Ventures and Industries Limited for every 5 equity shares of Rs. 2/- each held in Max Financial Services. The company has applied for approval from the Foreign Investment Promotion Board (FIPB) to enable issuance of the aforesaid new shares.

About Max Group

The Max Group is a leading Indian multi-business corporate with a commanding presence in the Life Insurance, Healthcare and Health Insurance sectors. In the financial year 2015, the Group recorded a consolidated turnover of Rs 14,877 Cr. It has a total customer base of over 7.5 million, nearly 300 offices spread across India and people strength of around 17,000 as on 31st March 2015. Max India Limited is a widely held company, listed on the BSE and the NSE. Its founder sponsor Analjit Singh holds 40.5% stake in the company. Other shareholders include some of the world’s best Institutional Investors such as Goldman Sachs, Temasek, IFC (Washington), Fidelity and New York Life.

For information please contact:

Nitin Thakur
nthakur@maxindia.com
+91 9873347428

Beedisha Chakrabarti
beedisha.chakrabarti@text100.co.in
+91 9899003192

Max India will own 51% and Bupa will own 49% in Max Bupa post requisite regulatory approvals
23rd November, 2015, New Delhi

Max Bupa Health Insurance (Max Bupa) today announced that its foreign parent Bupa has executed agreements to acquire an additional 23% stake in Max Bupa, one of India’s leading standalone health insurers. Bupa will pay around Rs 191 cr to Max India in an all cash transaction, to increase its stake in Max Bupa from 26% to 49%. Bupa was the first foreign insurer to announce its intent to increase its stake to 49% in its Indian health insurance subsidiary after the Government relaxed FDI participation rules for insurance companies.

Since that announcement in January 2015, Bupa and Max India have been working to align their JV agreements with the Insurance Laws (Amendment) Bill 2015 for Indian-owned and controlled businesses. The new agreements will come into force after the requisite regulatory clearances have been secured from the Foreign Investment Promotion Board (FIPB) and the Insurance Regulatory and Development Authority of India (IRDAI).

Launched in 2010, Max Bupa is already the 7th largest private health insurer in India. With a base of more than two million customers across India, it continues to be amongst the fastest growing stand-alone health insurers. Max Bupa has focused on building a retail customer and product portfolio via multiple sales channels including agency, bancassurance, telesales and online.

Its local parent Max India is one of India’s leading multi-business corporates and currently owns 74% of Max Bupa. Its foreign parent Bupa is a UK-headquartered global healthcare group, which holds 26% stake in the company.

Rahul Khosla, Managing Director, Max India Limited, welcomed the development. “Bupa’s stake increase is a clear affirmation of the huge growth opportunity for health insurance in India. The cash received from the transaction will support growth aspirations of the Max Group as well as for Max Bupa. I am confident that this renewed vote of confidence by Bupa, coupled with the recent strategic reorientation of the company will strengthen its position as an innovative leader in its field while setting new benchmarks in customer experience.”

Speaking at the occasion, David Fletcher, Managing Director of International Development Markets at Bupa said: “We see enormous opportunity in India to build on the great foundations of the last few years and use our global expertise to take the business to the next level. We are committed to growing an insurance business that not only provides the best quality healthcare funding but that is at the forefront of helping Indian people to live healthier lives.”

Max India has successfully managed several joint venture partnerships in its diverse businesses. Apart from Bupa, it also has partnerships with Japan’s Mitsui Sumitomo for its Life Insurance business and South Africa-based Life Healthcare for its healthcare business.

About Max Bupa Health Insurance

Max Bupa is a, 74:26, joint venture between Max India Limited, a multi-business corporate with expertise in life insurance and health care and Bupa, a leading international healthcare provider with 65 years of healthcare knowledge. Max Bupa brings together a combination of Bupa’s health insurance and customer service expertise with Max India’s understanding and experience of the Indian health and insurance sectors. Max Bupa offers quality health insurance services through a dedicated team of over 1400 people and its network of 26 offices across 16 cities – Delhi, Mumbai, Hyderabad, Chennai, Bangalore, Pune, Ludhiana, Chandigarh, Jaipur, Surat, Kochi, Kolkata, Patna, Goa, Jodhpur and Ludhiana. Max Bupa offers individual and family oriented health insurance policies for Indians across all age groups.

Max Bupa has a direct working relationship with a network of over 3500 top quality hospitals and healthcare providers, with plans to extend .Max Bupa services customers directly without third party involvement. For more details about the company and a list of all our network hospitals please visit www.maxbupa.com.

About Bupa

As a leading global health and care company, Bupa offers health insurance, medical subscription and other health and care funding products. Bupa runs care homes, retirement and care villages, primary care, diagnosic and wellness centres, hospitals and dental clinics. Bupa also provides workplace health services, home healthcare, health assessments and long-term condition management services.

Bupa has 29 million customers in more than 190 countries. With no shareholders, it invests its profits to provide more and better healthcare and fulfill its purpose: longer, healthier, happier lives.

Bupa employs almost 80,000 people, principally in the UK, Australia, Spain, Poland, New Zealand and Chile, as well as Saudi Arabia, Hong Kong, India, Thailand and the USA.

For more information, please visit: www.bupa.com

About Max India Group

Max India Group is a leading Indian multi-business corporate with a commanding presence in the Life Insurance, Healthcare and Health Insurance sectors. In the financial year 2015, the Group recorded a consolidated turnover of Rs 14,877 Cr. It has a total customer base of over 7.5 million, nearly 300 offices spread across India and people strength of around 17,000 as on 31st March 2015. Max India Limited is a widely held company, listed on the BSE and the NSE. Its founder sponsor Analjit Singh holds 40.5% stake in the company. Other shareholders include some of the worlds best Institutional Investors such as Goldman Sachs, Temasek, IFC (Washington), Fidelity and New York Life.

28th Oct 2015 New Delhi

Max Healthcare (MHC) today announced a partnership with Smart Group wherein MHC would acquire 51% stake in Saket City Hospital Pvt. Ltd., from Smart Health City Pte Ltd, the Singapore based BK Modi Group company which manages and operates the Delhi based Saket City Hospital (SCH). The transaction is subject to confirmatory diligence, requisite regulatory approvals and other customary conditions.

Located in the heart of South Delhi’s Saket area, SCH, which started operations in 2013, has 230 operational beds and is currently expanding to 300 beds. Max Healthcare plans to further expand this facility by ~900 additional beds, thereby expanding SCH’s capacity to 1200 beds. This addition represents a more than 50% increase compared to Max Healthcare’s current capacity and will significantly enhance access to quality healthcare.

Combined with Max Healthcare’s existing and contiguously located flagship facility (Max Super Specialty Hospital – Saket), Max Healthcare will have a footprint of more than 2000 beds in Saket – making it one of the largest single-location healthcare facilities in India.

MHC’s flagship quaternary & tertiary care hospital Max Super Specialty Hospital (MSSH) Saket is already one of North India’s premier destinations for tertiary & quaternary care including Centers of Excellence for several tertiary specialties. It is also home to a large number of top clinicians of national eminence and has a strong flow of both domestic and international patients. This development is expected to yield tremendous benefits of scale, synergy and quality across clinical, patient safety, customer service, management and financial aspects in tandem with the Max Healthcare network.

For Smart Health City, the partnership will progress Dr. B K Modi’s vision of creating a world-class Medical Office Building (MOB) in addition to SCH. The complementary medical services by MOB will include day care procedures, diagnostics, assisted living, rehabilitation centre, medical and clinical research etc.

The integrated healthcare facility comprising MSSH-Saket, SCH and MOB will collectively result in the development of a world class Medicity in the heart of India’s capital.

SCH will be rebranded as Max Smart Super Speciality Hospital to reflect the shared vision of the two partners.

Commenting on the partnership, Rahul Khosla, MD, Max India and Chairman, Max Healthcare, said, “The ability to create a 2,000 bed world class integrated Medicity, is a life changing opportunity for Max Healthcare and is in line with the company’s vision to be a best in class healthcare services provider. Max Healthcare is confident that this acquisition will provide significant opportunities through the realisation of a clear vision that includes setting up a world class centre dedicated to Oncology, development of high end Neurosciences capabilities, expansion of tertiary and quaternary specialities, installation of facilities to cater to transplants, deployment of high end technology solutions such as robotics to improve care and safety as well as to address the growing burden of lifestyle related, especially non communicable diseases.”

Talking about the partnership, Dr B K Modi, Founder & Chairman, Smart Global Group, said, “The partnership between Smart Health City and Max Healthcare will be transformational for healthcare delivery in North India. Max’s reputation as a premier healthcare provider and the expertise of their international JV partner, Life Healthcare, South Africa, will act as a catalyst for Smart Health City’s aspirations of creating a world class healthcare destination. I am now confident of providing India a health facility we will all be proud of.”

Reflecting on the development, Andre Meyer, CEO, Life Healthcare, said, “Max Healthcare is a critical part of our international portfolio. This Brownfield expansion will accelerate value creation. MHC is our first large scale healthcare platform outside Southern Africa and its continued success has strengthened our commitment to India in general and Max Healthcare in particular.”

Rajit Mehta, MD and CEO, Max Healthcare said, “We believe that we will be able to integrate SCH with our hospital network quickly to optimize clinical and service standards, realize cost efficiencies and attract more top clinicians to an already respectable talent pool.”

Dr Ashok V Chordiya, Vice Chairman, Saket City Hospital, said, “’This partnership will pave the way forward to superior care in medical as well as other complimentary and ancillary services providing comprehensive healthcare.”

Ernst & Young acted as the Advisor to the transaction.

About Max Healthcare
Max Healthcare (MHC) is an equal joint venture with Life Healthcare, South Africa, with both partners holding 45.94% equity stake each in MHC. It is the country’s leading comprehensive provider of standardized, seamless and international-class healthcare services. MHC is committed to the highest standards of medical and service excellence, patient care, scientific and medical education.

Max Healthcare has 13 facilities in North India, offering services in over 30 medical disciplines. Of this, 10 facilities are located in Delhi & NCR and the others in Mohali, Bathinda and Dehradun.

Max Healthcare has a base of over 2,500 doctors, 10,000 employees, and over 2.7 million patients from over 80 countries, across its network of 13 hospitals.

About Smart Health City

Smart Health City Pte Ltd is a Singapore based company and is the holding company for Saket City Hospital and for providing allied medical services. Inspired to create a global standard for healthcare, Smart Health City endeavors to create holistic healthcare destinations that will pioneer medical innovation and patient care experience.

For more information please contact:

Nitin Thakur
nthakur@maxindia.com
+91 9873347428

Beedisha Chakrabarti
beedisha.chakrabarti@text100.co.in
+91 9899003192

Sonali Bagchi
sonali.bagchi@text100.co.in
+91 9873242084

Max India’s Corporate Restructuring Plan Receives Formal Shareholder Approval

– Max India shareholders support the demerger with an overwhelming majority of 99.99%
– Significant milestone towards completing the three-way demerger
6th August 2015, New Delhi

The Hon’ble High Court of Punjab and Haryana has issued an order, taking on record the shareholders’ approval of Max India’s Composite Scheme of Arrangement for the demerger of the company and granted liberty to file a second motion petition. The Court-convened meeting of the equity shareholders of Max India was held on 4th July, 2015, in which 99.99% of the shareholders voted in favour of the Scheme.

The order allows the Company to move the second petition before the High Court. The Court will seek comments from the relevant regulatory authorities for the final approval of the demerger.

In addition, the company has applied to the Insurance Regulatory and Development Authority (IRDA) and the Foreign Investment Promotion Board (FIPB) for approval. The Company is hopeful of receiving the final court approval order by the end of September 2015.

Max India has already received approvals for its proposed corporate restructuring from the Securities and Exchange Board of India (SEBI), the two stock exchanges where it is listed — the Bombay Stock Exchange & the National Stock Exchange — as well as from the Competition Commission of India (CCI).

Besides the entity that is already listed, the two additional companies resulting from the Scheme will immediately file for listing of the shares with the stock exchanges following the final approval.

The proposed restructuring is a significant strategic event and is being undertaken to provide investors specific and undiluted access to Max India’s diverse lines of businesses, provide sharper focus to each underlying business and to unlock shareholder value.

Three holding companies will be listed upon completion of the demerger.

a) The existing company, Max India Limited, will be renamed ‘Max Financial Services Limited’ (MFS) and will focus solely on the Group’s flagship life insurance activity, through its subsidiary Max Life Insurance, in which it will hold 72% shareholding, making it the first Indian listed company exclusively focused on life insurance.

b) The second listed company will be named Max India Limited, and will continue to manage investments in the high potential sector of Healthcare and allied businesses. It will have three subsidiaries – Max Healthcare, Max Bupa and Antara Senior Living. The demerger will provide these businesses, which are currently in their growth and development phase, sharpened focus to fulfil their tremendous growth and value potential.

c) The third listed company will be named Max Ventures and Industries Limited (MVIL) and will house the Group’s manufacturing subsidiary, Max Speciality Films – an innovation leader in the Speciality Packaging Films business. In addition, MVIL will also leverage the platform provided by the Prime Minister’s ‘Make in India’ initiative and will explore fresh ideas for new ventures in the ‘wider world of business’.

Once the restructuring scheme is effective, after due regulatory approvals, Max India’s existing shareholders will retain one equity share of Rs 2/- in Max Financial Services Limited. They will additionally get one equity share of Rs. 2/- each of the new company Max India Limited for every one equity share held in Max Financial Services and one equity share of Rs. 10/- each of Max Ventures and Industries Limited for every 5 equity shares held in Max Financial Services.

About Max India

Max India Group is a leading Indian multi-business corporate with a commanding presence in the Life Insurance, Healthcare and Health Insurance sectors. In the financial year 2015, the Group recorded a consolidated turnover of Rs 14,877 Cr. It has a total customer base of over 7.5 million, nearly 300 offices spread across India and people strength of around 17,000 as on 31st March 2015. Max India Limited is a widely held company, listed on the BSE and the NSE. Its founder sponsor Analjit Singh holds 40.5% stake in the company. Other shareholders include some of the world’s best Institutional Investors such as Goldman Sachs, Temasek, IFC (Washington), Fidelity and New York Life.

For information please contact:

Nitin Thakur

nthakur@maxindia.com

+91 9873347428

Beedisha Chakrabarti

beedisha.chakrabarti@text100.co.in

+91 9899003192

Anisha Rakyan

arakyan@maxindia.com

+91 9811024077

Sonali Bagchi

sonali.bagchi@text100.co.in

+91 9873242084

Max Healthcare to acquire 76% stake in NCR based Pushpanjali Crosslay Hospital for Rs 287 Cr.

Max Healthcare (MHC) today announced that it has executed definitive agreements to acquire a controlling stake of 76% in NCR based Pushpanjali Crosslay Hospital (PCH) through a combination of fresh investment and acquisition of shares from existing promoters for the aggregate sum of Rs 287 Cr. Situated just 4 kms from Max Super Speciality Hospital in Patparganj, the 340-bedded Pushpanjali Crosslay is at a prime location along the East Delhi-Ghaziabad-Noida corridor. The hospital which has the capacity to expand up to 540 beds is NABH and NABL accredited and has been operational since 2010.

This move is in line with Max Healthcare’s ambitious growth strategy and follows its impressive financial performance and turn around to profitability. The new hospital, which will be rebranded under the Max Hospital umbrella, is expected to benefit immensely from clinical, management and financial synergies with the Max Healthcare network in general and Max Super Speciality Hospital, Patparganj in particular.

MHC is confident that this acquisition will provide significant expansion to the top and bottom line through sharing of resources, cost efficiencies, optimization of occupancy, and focusing on high growth specialities such as Oncology, Neuro Sciences, Renal Sciences including Kidney Transplant Program, Orthopedics and Cardiac Sciences.

Max Super Speciality Hospital, Patparganj, which is in close proximity to PCH, has already established a strong following and brand presence in the East Delhi & Western UP market and operates consistently at benchmark levels of occupancy. This acquisition, along with the existing hospitals in Patparganj, Noida and Greater Noida, will provide Max Healthcare a formidable presence in the East Delhi and Western UP region, which has a limited number of tertiary care hospitals catering to a population of more than 12.7 million.

Commenting on the acquisition, Rahul Khosla, Chairman, Max Healthcare and MD, Max India, said, “This acquisition comes at a fortuitous time for us when Max Healthcare has turned profitable and is poised for growth. Pushpanjali Crosslay is one of the few hospitals in NCR region which match Max Healthcare’s infrastructure and scale standards. Its 340 operational beds will allow immediate revenue and profit accretion to Max Healthcare. In addition, the reputation for excellence in medical services created by Max Healthcare, and particularly by our tertiary care hospital in Patparganj, will be hugely beneficial in attracting patients and top clinicians to our new hospital.”

Rajit Mehta, MD and CEO, Max Healthcare said, “Pushpanjali Crosslay is a welcome addition to our hospital network. We believe that we will be able to integrate it with our other hospitals fairly quickly to optimize clinical and service standards, realize cost efficiencies and attract more top clinicians to its already respectable clinical talent pool. Our patients should be confident of benefiting from the high levels of care and treatment that they have come to expect from any Max Hospital.”
PCH was founded by prominent Delhi clinician Dr Vinay Aggarwal along with a cooperative of around 250 doctors and 450 nursing staff. The property has 11 operation theatres, 4 labour rooms, 1 cath lab and is spread across 3.46 acres of freehold land, with a built up area of 3.84 lakh sq ft. With topof-the-line infrastructure and an opportunity to optimize the hospital’s operating model to drive efficiencies, the hospital presents MHC with immense scope for expansion and for transforming the hospital to a super speciality institution of choice in the near future. PCH had reported revenue of Rs 143 Cr at an EBIDTA margin of 14% in FY2014. Both these parameters underscore the potential for growth and upside by deploying Max Healthcare’s assets and expertise. Ernst & Young LLP acted as exclusive lead advisors on the transaction to PCH, while MHC’s side was led by Max Group and Life Healthcare’s in-house teams.

MHC plans to fund this transaction through a combination of debt and proceeds received from the recent stake increase by Life Healthcare & IFC.
Max Healthcare is on a steady path of growth, driven by significant increase in traction in its existing hospitals, and the ability to effectively harness growth from its new hospitals in Dehradun, Shalimar Bagh, Bathinda, Mohali and Greater Noida.

About Max Healthcare
Max Healthcare (MHC) is a joint venture with Life Healthcare, South Africa, and is the Country’s leading comprehensive provider of standardized, seamless and international-class healthcare services. It is committed to the highest standards of medical and service excellence, patient care, scientific and medical education.
Max Healthcare has 12 facilities in North India, offering services in over 30 medical disciplines. Of this, 9 facilities are located in Delhi & NCR and the others in Mohali, Bathinda and Dehradun. The Max network includes state-of-the-art tertiary care hospitals in Saket, Patparganj, Shalimar Bagh, Mohali, Bathinda and Dehradun, secondary care hospitals at Gurgaon, Pitampura, Noida & Greater Noida and an out-patient facility and speciality centre at Panchsheel Park. The Super Speciality Hospitals in Mohali and Bathinda are under PPP arrangement with the Government of Punjab.

Max Healthcare has a base of over 2,200 doctors, 9300 employees, and over 2.5 million patients from over 80 countries, across its network of 12 hospitals.

About Max India
The Max India Group is a leading Indian multi-business corporate with a commanding presence in the Life Insurance, Healthcare and Health insurance sectors. In the financial year 2015, the Group recorded consolidated revenue of Rs. 14,877 crore. It has a total customer base of over 8 million, nearly 300 offices spread across India and employee strength of over 70,000 persons as on 31st March 2015. Max India Limited is a widely held company, listed on the BSE and the NSE. Its founder sponsor Analjit Singh holds 40.5% stake in the company. Other shareholders include some of world’s best Institutional Investors such as Goldman Sachs, Temasek, IFC (Washington), Fidelity, New York Life.

About Life Healthcare
Life Healthcare is the second largest private hospital operators in South Africa. It currently owns and operates 63 facilities with 8322 beds in a comprehensive geographic spread over seven South African provinces and Botswana. It is also a leading provider of acute rehabilitation and mental health services in the country.

For information please contact:
Nitin Thakur nthakur@maxindia.com +91 9873347428

Beedisha Chakrabarti beedisha.chakrabarti@text100.co.in +91 9899003192

Anisha Rakyan arakyan@maxindia.com +91 9811024077

Sonali Bagchi sonali.bagchi@text100.co.in +91 9873242084

Max India Foundation salutes Breast Cancer survivors in a gala event ‘Celebrate Me’

~Held in Delhi on 22nd March 2015 as a culmination to cancer screening and awareness camps~

24th March, 2015, Delhi: Continuing its commitment and fight against Breast Cancer, Max India Foundation (MIF) culminated its month long breast cancer screening and awareness campaign with “Celebrate Me” event in Delhi. The event was organized to honor women who have survived their battle against Breast Cancer and emerged as ‘champions’ and to share their stories of tremendous determination and grit that can inspire one and many. The champions, attired in Ritu Kumar fashion wear, walked the ramp alongside doctors who helped them through the journey. Two poignant short stories, outlining the journeys of champions, as a first person account, were also showcased at the event.

The gala event featured breast cancer survivors on the ramp with hair and makeup done by Dr Blossom Kochar of Aroma Magic. The evening showcased some women-centric performances by Rekha Surya, a renowned Hindustani classical music singer and disciple of Begum Akhtar; and urban folk band Folka Dots. The famous Bharatnatyam dancer Rama Vaidya Nathan, accompanied by her daughter, choreographed and performed a beautiful dance depicting the ups and downs of life – “What is Life”. The evening was graced by Shweta Bachhan Nanda walking the ramp as the showstopper to endorse support to the survivors. Sharing her thoughts with the audience, she said, “Any kind of cancer brings a stigma with it. One must remember that cancer is a tough disease but those who fight it are tougher. Well-being is as much a part of the mind and spirit as the body. We shouldn’t just celebrate those suffering from cancer but the care-givers who are constantly there for care and support through every milestone in the journey of people championing cancer. I congratulate the women present here this evening for their indomitable spirits’. They are really heroes. With this event, the survivors or “champions “ have been infused with a great sense of confidence and self-esteem. They have bonded as a group and feel connected and supported.’

Mr Analjit Singh, Chairman Max India and Managing Trustee of the Foundation was personally present at the event along with Mr Rahul Khosla (Managing Director, Max India) and Mohit Talwar (Deputy Managing Director, Max India). Other seniors like Mr Rajesh Sud (Managing Director, Max Life Insurance) and Mr Rajit Mehta (Deputy Managing Director, Max Healthcare) were also present. Speaking at the event, Mr. Singh shared a profound narration of a young surgeon who succumbed to cancer. He said, “Persistence is the true spirit of existence. Today, as we gather here to commemorate exceptional individuals, we pay tribute to them not simply because they have conquered a malady but because they have left lessons with us on how to battle and persist against various odds that life throws at us. We all have to work mindfully to contribute to society and develop everything around us to protect ourselves from how life has become now. I hope we all spread consciousness on how to live healthy lives.”

Ms. Mohini Daljeet Singh, Chief Executive of Max India Foundation, talking about strong commitment towards the cause said, “Cancer is a leading cause of death globally. Many of these deaths can be prevented by early detection, treatment and good palliative care. Max India Foundation takes immense satisfaction in persistently providing patients across the country with support services for diagnosis and cure. We recently received funding from Australian High Commission under their Direct Aid Programme for cancer awareness activities and this support enthuses us all the more to increase the outreach of our local campaigns to educate people in preventive health measures. ‘Celebrate me’, is aimed at emboldening and equipping cancer survivors by bringing to light their encouraging experiences on a multi-stakeholder platform. It is a simple yet powerful initiative to strengthen and promote benefits arising out of regular health check-ups specifically pertaining to breast cancer.”

Mr. Gregory Harvey, a representative from the Australian High Commission at the event said, ‘The work that the Max India Foundation, to provide mobile screening camps in Delhi and Punjab, is doing is extremely significant. One of the key aspects of curing cancer is improving early and accurate detection. It increases survivor rates and also ameliorates health outcomes and quality of life of patients. We look forward to continuing and maintaining our relationship with the Foundation to continue addressing such crucial issues.’

MIF, the CSR arm of Max group, organized a month long Cancer screening and awareness campaign in Delhi NCR and across all 8 blocks of Bathinda, Punjab. The campaign, which commenced on 23rd February, 2015, reached out to over 500 women through 13 camps in the 2 states. Free-of-cost screening for detection of cancers of breast, cervix and oral cavity was provided at these camps. Awareness on cancer prevention and cure were integrated with these camps on a large scale. The various IEC activities to generate awareness among the communities included street plays, talks by expert doctors, screening of movie, pamphlets etc.

About Max India Foundation

Max India Foundation (MIF), founded in 2008, is the social service arm of Max India Limited. The primary areas of work are curative and preventive healthcare, health awareness for underprivileged population; and initiatives on a health oriented environment. The foundation organizes immunization camps for children and multispecialty health camps for all age groups; operates permanent health centers; supports medical and surgical treatments at Max group of hospitals and artificial limbs and calipers for the disabled; caters to nutritional needs of children; creates health awareness; and carries out disaster relief work. Guided by its vision of ‘Caring for life’, the foundation has benefitted over 1.2 million people from the underserved communities in 22 states across the country in partnership with more than 400 NGOs.

Max India Foundation has been awarded the Golden Peacock Global CSR Award in 2011 and Golden Peacock Award for CSR 2012, The BSE 6TH Social And Corporate Governance Awards – 2010, 5th and 7th INDY‟S Stars of the Industry Awards 2011 for Best CSR, and Blue Dart Award for CSR on World CSR Day in 2012 and 2013, for the significant impact the Foundation has made to the lives of the needy in the last five years.

For further information, please contact:

Text100 – Anubhuti Sharma, 9654367013, anubhuti.sharma@text100.co.in

Text100 – Garima Sharma, 9899175275, Garima.sharma@text100.co.in

Max India announces the Embedded Value (EV) for its life insurance business as at 31st March 2015

– EV based market consistent methodology stands at Rs. 5,232 Cr., implying total and operating returns of 28.1% and 22.3% respectively

Max India Ltd. today announced the Embedded Value (EV) for its life insurance business, Max Life, at Rs. 5,232 Cr. as at 31st March 2015, based on Market Consistent methodology. The Return on EV for FY2015 is an impressive 28.1% while the Operating Return on EV is 22.3%. The Value of New Business (VNB) written during FY2015 is Rs 460 Cr. with the new business margin at a healthy, 23.4%. The growth is supported by strong fundamentals both on the existing business as well as a continued focus on new profitable business.

EV and VNB are important metrics for the valuation of a life insurance business as the company is generally valued at a multiple to its EV. For instance, Mitsui Sumitomo Insurance’s investment in Max Life Insurance was at an implied EV multiple of around 3 times.

Embedded Value (EV) of a life insurance company comprises two key elements — a) Net Asset Value or the Net Worth of the company, which represents the market value of the company’s assets attributable to the shareholders, and b) the Present Value of the company’s future expected profits from its existing business portfolio as at the date of valuation.

Max Life transitioned its EV calculation to a Market Consistent methodology from the earlier traditional approach (Traditional Embedded Value – TEV). This follows market practice in developed markets, where life insurers have moved to adopt market consistent methodologies.

A market consistent methodology approach better reflects the embedded value of an insurance company by explicitly allowing for insurance and economic risks rather than using an implicit overall allowance for risks through a Risk Discount Rate (RDR) in the traditional approach. In addition, the market-consistent approach is more objective where asset and liability cash flows are valued using assumptions consistent with those applied to similar cash flows in the capital markets. The decision to adopt the market consistent methodology was approved by the Max Life Board on 21st May 2015. The EV for FY2014, as per the TEV methodology was Rs 3953 Cr.

Max Life has been on a steady growth trajectory over the past 4 years and continued to register exceptional performance in the previous financial year as well. The company reported 12% premium growth and Rs 477 Cr shareholder profits for FY2015. Max Life maintained its position as the 4th largest private player in the life insurance industry (individual business), and the largest non-bank private life insurance company. The company wiped out all its accumulated losses during FY2015.

Max India Ltd. also announced its results today with its consolidated revenue for FY15 at Rs 14,877 Cr, growing 27% and consolidated PAT at Rs 365 Cr, growing 75%.

About Max India
Max India Group is a leading Indian multi-business corporate with a commanding presence in the Life Insurance, Healthcare and Health Insurance sectors. In the financial year 2015, the Group recorded a consolidated turnover of Rs 14,877 Cr. It has a total customer base of over 7.5 million, nearly 300 offices spread across India and people strength of around 17,000 as on 31st March 2015. Max India Limited is a widely held company, listed on the BSE and the NSE. Its founder sponsor Analjit Singh holds 40.5% stake in the company. Other shareholders include some of the world’s best Institutional Investors such as Goldman Sachs, Temasek, IFC (Washington), Fidelity and New York Life.

About Max Life
Max Life Insurance Company Ltd. (MLIC) is a joint venture between Max India Ltd. and Mitsui Sumitomo Insurance Co. Ltd. Mitsui Sumitomo Insurance is a part of MS&AD Insurance Group, which is amongst the leading general insurers in the world. Max Life Insurance, one of India’s leading life insurers, offers comprehensive life insurance and retirement solutions for long-term savings and protection.

A financially strong and stable company with focus on quality of advice, sound investment expertise and service excellence, Max Life Insurance has set in place value-driven culture and corporate governance through its superior human capital. The Company has a countrywide diversified distribution model, including the country’s leading agent advisors, exclusive corporate agency arrangement with Axis Bank and several other partners.

Max Bupa set to become one of the first to benefit from new insurance FDI Limited

BUPA TO INCREASE STAKE IN MAX BUPA TO 49%

Max Bupa Health Insurance (Max Bupa) today announced that it is set to become one of the first companies in India to benefit from the proposed increased limit for foreign direct investment (FDI) in insurance. Following the Insurance Laws Amendment Ordinance 2014 receiving legislative assent in the 2015 Budget Session of Parliament, Bupa, the international healthcare group, proposes to increase its stake in Max Bupa from 26% to 49%. Bupa will submit formal applications to the relevant authorities for the regulatory approvals required in order to increase its stake.

Max Bupa, a leading Indian standalone private health insurer, is a joint venture between Max India, one of India’s leading multi business corporates, which owns 74% of Max Bupa, and Bupa, the UK-headquartered global healthcare group, which owns 26%. Launched in 2010, Max Bupa is already the 7th largest private health insurer in India. With a customer base of two million across India, it continues to be amongst the fastest growing stand-alone health insurers. Max Bupa has focused on building a retail customer and product portfolio via multiple sales channels including agency, bancassurance, telesales and online.

Commenting on the decision to increase Bupa’s stake in Max Bupa, David Fletcher, Managing Director of International Development Markets at Bupa said: “This decision underlines Bupa’s commitment to the Indian health insurance market and represents a major milestone in the development of Max Bupa. With our partners Max India, we are committed to supporting Max Bupa’s growth and helping Indian consumers live healthier and more successful lives.”

Rahul Khosla, Managing Director, Max India Limited, Bupa’s JV partner, welcomed the decision. “Max Bupa has established its brand, developed a wide retail customer base and grown its share in the attractive health insurance market. As Max Bupa prepares itself for its next wave of growth, it will stand to benefit from Bupa’s expertise in areas such as under-writing health risks and product innovation. Bupa’s intention to increase its stake is testimony to the huge opportunity for health insurance in India and Max India’s reputation in successfully managing joint ventures.”

Max India is one of India’s leading multi business corporates with interests in life insurance, healthcare and health insurance. Since its inception almost three decades ago, it has successfully managed several joint venture partnerships. Talking about the recent reforms in India, Mr Khosla added, “Given that the Government has been in office for just six months, I congratulate the Prime Minister, Mr Modi and the Finance Minister, Mr. Jaitley for finding a way to drive the passage of such a major sectoral reform. This Government is pro business and has now also shown it means business.”

The application to increase Bupa’s shareholding in Max Bupa will be subject to successful completion of the law-making process as well as all relevant regulatory and legal approvals.

About Max Bupa Health Insurance

Max Bupa is a, 74:26, joint venture between Max India Limited, a multi-business corporate with expertise in life insurance and health care and Bupa, a leading international healthcare provider with 65 years of healthcare knowledge. Max Bupa brings together a combination of Bupa’s health insurance and customer service expertise with Max India’s understanding and experience of the Indian health and insurance sectors. Max Bupa offers quality health insurance services through a dedicated team of over 1400 people and its network of 26 offices across 16 cities – Delhi, Mumbai, Hyderabad, Chennai, Bangalore, Pune, Ludhiana, Chandigarh, Jaipur, Surat, Kochi, Kolkata, Patna, Goa, Jodhpur and Ludhiana. Max Bupa offers individual and family oriented health insurance policies for Indians across all age groups.

Max Bupa has a direct working relationship with a network of over 3500 top quality hospitals and healthcare providers, with plans to extend . Max Bupa services customers directly without third party involvement. For more details about the company and a list of all our network hospitals please visit  www.maxbupa.com.

About Bupa

As a leading international healthcare group, Bupa offers health insurance and other health funding products, and runs care homes, retirement villages, hospitals, diagnostic and primary care centres and dental clinics. Bupa also provides workplace health services, home healthcare, health assessments and long-term condition management services.

 

Bupa has over 22 million customers in 190 countries and territories. With no shareholders, it invests its profits to provide more and better healthcare and fulfill its purpose: longer, healthier, happier lives.

 

Bupa employs more than 70,000 people, principally in the UK, Australia, Spain, Poland, New Zealand and Chile, as well as Saudi Arabia, Hong Kong, India, Thailand and the USA.

 

For more information, please visit:www.maxbupa.com.

About Max India

Max India Group is a leading Indian multi-business corporate with a commanding presence in the Life Insurance, Healthcare and Health insurance sectors. In the financial year 2014, the Group recorded a consolidated turnover of Rs 117 billion. It has a total customer base of over 7.5 million, nearly 300 offices spread across India and people strength of around 17,000 as on 31st March 2014. Max India Limited is a widely held company, listed on the BSE and the NSE. Its founder sponsor Analjit Singh holds 40.5% stake in the company. Other shareholders include some of world’s best Institutional Investors such as Goldman Sachs, Temasek, IFC (Washington), Fidelity and New York Life.

Bupa

Vasudevan Rangarajan

Office: +91 124 4131 481

Mobile : +91 95602 77755

Email: vasudevan.rangarajan@edelman.com

Max India

Nitin Thakur

Mobile: +91 9873347428

E-mail: nthakur@maxindia.com

Anisha Rakyan

Mobile: +91 9811024077

E-mail:arakyan@maxindia.com

Max India set for mega corporate restructuring

Demerges into 3 business verticals – Life Insurance, Health & Allied businesses and Manufacturing Industries

The Board of Max India Ltd, approved a Corporate Restructuring plan to vertically split the company through a demerger, into three separate listed companies, to give investors specific and undiluted access to its diverse lines of businesses, provide sharper focus to each underlying business, and unlock shareholder value. The Board also approved divestment of its clinical research business.

Upon completion of the demerger, the existing company, Max India Limited, is proposed to be renamed ‘Max Financial Services Limited’ (MFS) upon demerger and will focus solely on the group’s flagship life insurance activity, through its 72.1% shareholding in Max Life, making it the first Indian listed company exclusively focused on life insurance. The Insurance Amendment Ordinance, recently promulgated by the President of India, and widely expected to be approved as an Act, has created renewed investor interest in the life insurance sector.

Upon completion of the demerger it is proposed to name the second vertical Max India Limited, which will continue to manage investments in the high potential Health and Allied businesses, essentially comprising : – Max Healthcare, Max Bupa, Antara Senior Living and supported by a Corporate Management Services team. The demerger will provide these businesses, which are currently in their growth and development phases, sharpened focus to fulfil their tremendous potential. The Corporate Management Services team will manage a shared services centre, which will provide functional support to all 3 verticals.

The third vertical will house the investment activity in the group’s manufacturing subsidiary, Max Speciality Films – an innovation leader in the Speciality Packaging Films business – and will be named Max Ventures and Industries Limited (MVIL). Set-up in 1989, the Speciality Packaging Films business has been consistently profitable. It recorded revenues of Rs. 746 Cr. and profit of Rs. 14 Cr in FY2014. The Prime Minister’s new initiative ‘Make in India’ is set to provide fresh impetus to this business and for this vertical, to start looking at fresh ideas in the ‘wider world of business’.

Max India has also initiated action for the divestment of its entire 100% stake in the clinical research business. Max Neeman entities in India and United States are proposed to be divested to a Canadian Contract Research Organization (CRO), JSS Medical Research Inc., for a consideration of US$ 1.5 Million, subject to successful completion of due diligence and signing of definitive agreements, expected by mid-February.

Once the demerger scheme is effective, after due regulatory approvals, Max India’s shareholders will retain one equity share of Rs 2/- in Max Financial Services Limited and will additionally get one equity share of Rs. 2/- each of Max India Limited for every one equity share of Rs. 2/- each held in Max Financial Services, and one equity share of Rs. 10/- each of Max Ventures and Industries Limited for every 5 equity shares of Rs. 2/- each held in Max Financial Services.

Max India currently has cash reserves of Rs. 605 Cr. as at December 31, 2014. It is proposed to split the cash reserves as on Appointed Date of April 1, 2015 between the 3 listed companies such that Max Financial Services Limited will hold Rs. 150 Cr., Max Ventures and Industries Limited will hold Rs. 10 Cr. and the balance, likely to be over Rs. 400 Cr., will be held by the newly formed Max India Limited.

The top leadership of Max India – Analjit Singh (Chairman), Rahul Khosla (Managing Director) and Mohit Talwar (Deputy Managing Director) – will continue in their roles and upon demerger, will continue to hold appropriate roles in the demerged entities of the Max group. The top leadership of the Max group’s operating companies will continue in their respective roles – Rajesh Sud, MD and CEO of Max Life and Chairman, Max Bupa, Rajit Mehta, DMD of Max Healthcare, Tara Singh Vachani, CEO of Antara, Jaideep Wadhwa, CEO of MSF and Mohini Daljeet Singh, Chief Executive of Max India Foundation.

Setting the context for the demerger, Analjit Singh, Chairman, Max India Ltd, said “The new government is setting a rapid pace for economic reforms. This structural reconfiguration readies us to capitalize on opportunities created by the anticipated all round growth acceleration and to henceforth look at the wider world of business opportunities.”

Explaining the rationale for the demerger, he added “Our bouquet of businesses is diverse, but each has considerable value and growth potential. This demerger will provide investors with a choice to continue to be associated with all these businesses, or only specifically invest in the set of businesses that suit their respective investment philosophy. For instance, the high growth healthcare business is poised to add significant additional capacity in future. The health insurance and senior living business are less than 5 years in operation and need significant focus, attention and capital, while the relatively mature business of life insurance provides a balance of growth and profitability.”

The Appointed Date for the demerger is April 1, 2015, and the demerger is expected to be completed within the next six to nine months.

The proposed demerger is subject to approval by Max India shareholders, its creditors and relevant regulatory authorities.

About Max India

Max India Group is a leading Indian multi-business corporate with a commanding presence in the Life Insurance, Healthcare and Health insurance sectors. In the financial year 2014, the Group recorded a consolidated turnover of Rs 117 billion. It has a total customer base of around 8 million, over 300 offices spread across India and people strength of around 18,000 as on 31st March 2014. Max India Limited is a widely held company, listed on the BSE and the NSE. Its founder sponsor Analjit Singh holds 40.5% stake in the company. Other shareholders include some of world’s best Institutional Investors such as Goldman Sachs, Temasek, IFC (Washington), Fidelity and New York Life.

For more details contact:

Nitin Thakur

Head – Communications
Max India
Max House, Okhla – III,
New Delhi-110 020
Tele # 2693 3601-10 extn. 196
Cell # +91 9873347428
E-mail: nthakur@maxindia.com

Anisha Rakyan
Cell # +91 9811024077

E-mail: arakyan@maxindia.com

Garima Sharma

Cell # +91 9899175275

E-mail: Garima.Sharma@text100.co.in

Ritika Singh
Cell # +91 9654971565

E-mail: Ritika.Singh@text100.co.in

Max India Foundation and the Karmapa’s Kagyupa International Monlam Trust Launch MultiSpeciality Health Camp for the Poor

Bodhgaya, Bihar 3–5 January 2015

January 3rd, 2015, Bodhgaya .On the occasion of the 32nd Kagyu Monlam Prayers for World Peace, led by His Holiness the 17th Karmapa Ogyen Trinley Dorje, the Max India Foundation (MIF) is delighted and humbled to join hands with the Kagyupa International Monlam Trust in bringing better health to the residents of Bodhgaya through a three-day Multi- Speciality Health Camp. MIF’s mission is to make quality healthcare services available to the poor and the needy. Since its establishment in 2008, MIF have conducted multi-speciality camps in different parts of India, including remote tribal areas in Madhya Pradesh, Andhra Pradesh, Ladakh and Punjab. In recognition of its deep commitment to Corporate Social Responsibility (CSR) and the significant impact the Foundation has made on the lives of the needy, Max India Foundation has received numerous awards including the prestigious Golden Peacock Global Award for Best CSR for three years running.

The Karmapa Ogyen Trinley Dorje is one of the foremost Tibetan Buddhist leaders after the Dalai Lama and the Panchen Lama. The Karmapa established the Kagyupa International Monlam Trust in 2006 to bring together his devotees to pray for world peace in Bodhgaya, Bihar, the place of Lord Buddha’s enlightenment., . Thisyear’s prayer gathering is attended by over 10,000 devotees from across the Himalayas and over 30 countries of the world.

In addition to the prayer gathering, the Kagyupa International Monlam Trust carries out other charitable activities including an annual health camp for the local residents, a soup kitchen for the poor, distribution of blankets for the needy and an animal health camp. Further, based on the principle of interdependence and interconnectedness, the Karmapa strongly advocates personal responsibility in caring for those around us and for the environment.

The Max India Foundation and the Kagyupa International Monlam Trust are pleased to make an auspicious start of 2015 with the launching of a Multi-Speciality Health Camp in Bodhgaya from 3–5 January 2015. The Max India Foundation team comprises specialists in internal medicine, gynaecology, dermatology and a pediatrician. They will be present at the camp and provide necessary consultation and medicines to the needy. Jan Jagran Sansthan, a local grass roots NGO based in Patna, is supporting the outreach to the local communities. Through our common aspiration, it is hoped that this joint endeavour will contribute to well-being of all the residents of Bodhgaya.

About MIF

Max India Foundation (MIF), the Corporate Social Responsibility arm of Max India Group, started its work in 2008. Max India Foundation spearheads the CSR initiatives of Max India Group of Companies. Social initiatives for Max Life Insurance, Max Healthcare, Max Speciality Films, Max Bupa, and Max India Corporate are planned and executed through the Foundation. In a short span of about five years, Max India Foundationhas been able to make a significant difference in the lives of over 5,00,000 people across more than 360 locations throughout India. Max India Foundation works with over 250 reputed NGO partners working with them at the grassroots level in many locations. MIF’s mission is to provide quality healthcare to the underprivileged and facilitate awareness of health related issues and an eco-friendly environment.

Completing six years of operations in January 2014, Max India Foundation has proved its track record and emerged as a leader and role model in healthcare for corporate volunteers.. Max India Foundation has created a niche for itself in this area by focusing in special areas:·

Providing quality healthcare for people of the economically weaker section of society

  • Creating awareness ofhealth issues such as women’s health, cancer, diabetes, cardiovascular diseases, and immunisation of children
  • Working towards a sustainable and eco-friendly environment

Max India Foundation supports programmes that facilitate quality healthcare for the underprivileged population. To achieve this, they have joined hands with similar spirited organizations covering a wide spectrum of initiatives. Some of these initiatives include: Surgeries and Pan India Immunization; Health Camps; Artificial Limbs and Polio Calipers Camp.

Some of the reputable NGO’s MIF has partnered regularly with are CanSupport, SOS Children’s Village, Manav Seva Sannidhi, and Chinmaya Mission. Together they undertake initiatives such as pan India immunization programs, surgeries for underprivileged, artificial limb and polio calipers camp, multi-speciality camps, blood donation camps, onboard rail operation theater known as Life Line Express, the Clean Delhi Clean Yamuna campaign, and support for disaster relief victims.